1. Tanshinone IIA Facilitates TRAIL Sensitization by Up-regulating DR5 through the ROS-JNK-CHOP Signaling Axis in Human Ovarian Carcinoma Cell Lines.
   Chia-che Chang, 0 CrossRef
2. Efficacy of combining ING4 and TRAIL genes in cancer-targeting gene virotherapy strategy: first evidence in preclinical hepatocellular carcinoma
   A Galal El-Shemi et al, 2018, Gene Ther CrossRef
3. Berberine, an Epiphany Against Cancer
   Luis Guamán Ortiz et al, 2014, Molecules CrossRef
4. Molecular chemotherapeutic potential of butein: A concise review.
   Rajapaksha Gedara Prasad Tharanga Jayasooriya et al, 2018, Food Chem Toxicol CrossRef
5. ShDcR3 sensitizes TRAIL-resistant HCC cells by inducing caspase-dependent apoptosis while suppressing NF-κB dependent cFLIPL expression
   Dong-Yu Liang et al, 2018, PLoS ONE CrossRef
6. Anti-cancer activity of ZnO chips by sustained zinc ion release
   Seong-Hee Moon et al, 2016, Toxicology Reports CrossRef
7. Downregulation of SKP2 in Papillary Thyroid Cancer Acts Synergistically With TRAIL on Inducing Apoptosis via ROS.
   Poyil Pratheeshkumar et al, 2018, J Clin Endocrinol Metab CrossRef
8. Lambertianic Acid Sensitizes Non-Small Cell Lung Cancers to TRAIL-Induced Apoptosis via Inhibition of XIAP/NF-κB and Activation of Caspases and Death Receptor 4
   Deok Ahn et al, 2018, IJMS CrossRef
9. A chemically induced proximity system engineered from the plant auxin signaling pathway
   Weiye Zhao et al, 2018, Chem. Sci. CrossRef
10. Glutamine deprivation sensitizes human breast cancer MDA-MB-231 cells to TRIAL-mediated apoptosis
    Matharage Gayani Dilshara et al, 2017, Biochemical and Biophysical Research Communications CrossRef
11. Review of the Ubiquitin Role in DNA Repair and Tumorigenesis, with Emphasis in Breast Cancer Treatment; Current Data and Future Options
    Despoina Mourtzoukou et al, 2018 CrossRef
12. Inducing cell death in Glioblastoma
    Shahed Tappuni et al, 2015, BMC Proc CrossRef
13. CIB1 depletion with docetaxel or TRAIL enhances triple-negative breast cancer cell death
    Alexander H. Chung et al, 2019, Cancer Cell Int CrossRef
14. Advances in the study of berberine and its derivatives: a focus on anti-inflammatory and anti-tumor effects in the digestive system
    Kun Zou et al, 2017, Acta Pharmacol Sin CrossRef
15. Epicatechin Prevents Methamphetamine-Induced Neuronal Cell Death via Inhibition of ER Stress
    Youra Kang et al, 2019, Biomol Ther CrossRef
16. How plausible is the use of dietary n-3 PUFA in the adjuvant therapy of cancer?
    Simona Serini et al, 2016, Nutr. Res. Rev. CrossRef
17. Co-delivery of chemotherapeutics and proteins for synergistic therapy
    Chaoliang He et al, 2016, Advanced Drug Delivery Reviews CrossRef
18. Sea Cucumber (Stichopus japonicas) F2 Enhanced TRAIL-Induced Apoptosis via XIAP Ubiquitination and ER Stress in Colorectal Cancer Cells
    Jung Lim Kim et al, 2019, Nutrients CrossRef
19. Cannabidiol Enhances the Therapeutic Effects of TRAIL by Upregulating DR5 in Colorectal Cancer
    Jung Lim Kim et al, 2019, Cancers CrossRef
20. Irradiation enhances susceptibility of tumor cells to the antitumor effects of TNF-α activated adipose derived mesenchymal stem cells in breast cancer model
    Hemn Mohammadpour et al, 2016, Sci Rep CrossRef
21. hnRNPK inhibits GSK3β Ser9 phosphorylation, thereby stabilizing c-FLIP and contributes to TRAIL resistance in H1299 lung adenocarcinoma cells
    Xuejuan Gao et al, 2016, Sci Rep CrossRef
22. Tumor necrosis factor-related apoptosis-inducing ligand modulates angiogenesis and apoptosis to inhibit non-small cell lung carcinoma tumor growth in mice
    Yuanmei Chen et al, 2019, J Int Med Res CrossRef
23. Inflammatory and Apoptotic Regulatory Activity of Tanshinone IIA in Helicobacter pylori-Infected Cells
    Guan-Yu Chen et al, 2016, Am. J. Chin. Med. CrossRef
24. TRAIL and TRAIL receptors in patients with laryngeal cancer
    Evren Erkul et al, 2016, Head Neck CrossRef
25. Downregulation of SNAIL sensitizes hepatocellular carcinoma cells to TRAIL-induced apoptosis by regulating the NF-κB pathway
    ZHAOJUN WAN et al, 2015 CrossRef
26. Programmed cell death in aging.
    John Tower, 2015, Ageing Res Rev CrossRef
27. Inhibition of p38 mitogen-activated protein kinase potentiates the apoptotic effect of berberine/tumor necrosis factor-related apoptosis-inducing ligand combination therapy
    Alaa Refaat et al, 2015, Oncol Lett CrossRef
28. Gambogic acid induces apoptosis and sensitizes TRAIL-mediated apoptosis through downregulation of cFLIPL in renal carcinoma Caki cells.
    Ji Hoon Jang et al, 2016, Int. J. Oncol. CrossRef
29. Combined therapy with oncolytic adenoviruses encoding TRAIL and IL-12 genes markedly suppressed human hepatocellular carcinoma both in vitro and in an orthotopic transplanted mouse model
    Adel Galal El-Shemi et al, 2016, J Exp Clin Cancer Res CrossRef
30. Tumor-penetrating peptide fused to a pro-apoptotic peptide facilitates effective gastric cancer therapy
    Ying Huang et al, 2017 CrossRef
31. sTRAIL-iRGD is a promising therapeutic agent for gastric cancer treatment
    Ying Huang et al, 2017, Sci Rep CrossRef
32. Novel targets for sensitizing breast cancer cells to TRAIL-induced apoptosis with siRNA delivery
    Bindu Thapa et al, 2018, Int. J. Cancer CrossRef
33. Glucosamine Enhances TRAIL-Induced Apoptosis in the Prostate Cancer Cell Line DU145
    Chao Sun et al, 2019, Medicines CrossRef
34. Interplay between inflammation and cancer
    Rekha Khandia et al, 2019 CrossRef
35. The fungal metabolite chaetocin is a sensitizer for pro-apoptotic therapies in glioblastoma
    Ezgi Ozyerli-Goknar et al, 2019, Cell Death Dis CrossRef
36. Polymer therapeutics
    Kyung Hyun Min et al, 2020 CrossRef
37. Overexpression of PARP is an independent prognostic marker for poor survival in Middle Eastern breast cancer and its inhibition can be enhanced with embelin co-treatment
    Abdul Khalid Siraj et al, 2018, Oncotarget CrossRef
38. Cell death and restoration of TRAIL-sensitivity by ciglitazone in resistant cervical cancer cells
    Marie-Laure Plissonnier et al, 2017, Oncotarget CrossRef
39. Inhibition of never in mitosis A (NIMA)-related kinase-4 reduces survivin expression and sensitizes cancer cells to TRAIL-induced cell death
    So Jung Park et al, 2016, Oncotarget CrossRef
40. Suppression of TRPM7 enhances TRAIL‐induced apoptosis in triple‐negative breast cancer cells
    Chiman Song et al, 2020, J Cell Physiol CrossRef
41. Picropodophyllotoxin, an Epimer of Podophyllotoxin, Causes Apoptosis of Human Esophageal Squamous Cell Carcinoma Cells Through ROS-Mediated JNK/P38 MAPK Pathways
    Ah-Won Kwak et al, 2020, IJMS CrossRef
42. Advances in the mechanisms of action of cancer-targeting oncolytic viruses (Review)
    Cun‑Zhi Lin et al, 2018, Oncol Lett CrossRef
43. Romo1 Inhibition Induces TRAIL-Mediated Apoptosis in Colorectal Cancer
    Min Jee Jo et al, 2020, Cancers CrossRef
44. Overcoming therapeutic efficiency limitations against TRAIL-resistant tumors using re-sensitizing agent-loaded trimeric TRAIL-presenting nanocages
    Hyeonwoo Je et al, 2021, Journal of Controlled Release CrossRef
45. Inhibition of the Growth of Breast Cancer-Associated Brain Tumors by the Osteocyte-Derived Conditioned Medium
    Tomohiko Sano et al, 2021, Cancers CrossRef
46. A review on chemistry, source and therapeutic potential of lambertianic acid
    Md Shahinozzaman et al, 2021 CrossRef
47. RuvBL1 Maintains Resistance to TRAIL-Induced Apoptosis by Suppressing c-Jun/AP-1 Activity in Non-Small Cell Lung Cancer
    Hao Li et al, 2021, Front. Oncol. CrossRef
48. Dual mechanistic TRAIL nanocarrier based on PEGylated heparin taurocholate and protamine which exerts both pro-apoptotic and anti-angiogenic effects
    Jeong Uk Choi et al, 2021, Journal of Controlled Release CrossRef
49. Internalizing RGD, a great motif for targeted peptide and protein delivery: a review article
    Zeinabosadat Davoodi et al, 2022, Drug Deliv. and Transl. Res. CrossRef
50. Paradoxical effects of osteoprotegerin on vascular function: inhibiting inflammation while promoting oxidative stress?
    Nhat-Tu Le et al, 2022, Clin Sci (Lond) CrossRef
51. Diffuse Intrinsic Pontine Glioma (DIPG): Breakthrough and Clinical Perspective
    Maria Grazia Perrone et al, 2021, CMC CrossRef
52. Cell Trafficking at the Intersection of the Tumor–Immune Compartments
    Wenxuan Du et al, 2022, Annu. Rev. Biomed. Eng. CrossRef
53. Frankincense essential oil nanoemulsion specifically induces lung cancer apoptosis and inhibits survival pathways
    Ahmed A. Abd-Rabou et al, 2022, Cancer Nano CrossRef
54. An integrative systems biology approach to overcome venetoclax resistance in acute myeloid leukemia
    Michelle Przedborski et al, 2022, PLoS Comput Biol CrossRef
55. Cafestol, Kahweol and Their Acylated Derivatives: Antitumor Potential, Pharmacokinetics, and Chemopreventive Profile
    M.A.E. Silva et al, 2022, Food Reviews International CrossRef
56. A theranostic abscisic acid-based molecular glue
    Jing Chen et al, 2023, Chem. Sci. CrossRef
57. Current approaches in enhancing TRAIL therapies in glioblastoma
    Morrent Thang et al, 2023 CrossRef
58. Targeting ferroptosis unveils a new era for traditional Chinese medicine: a scientific metrology study
    Siyang Cao et al, 2024, Front. Pharmacol. CrossRef
59. TRAIL-induced apoptosis and proteasomal activity – Mechanisms, signalling and interplay
    Chiara Boccellato et al, 2024, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research CrossRef
60. Apoptosis of Pancreatic Cancer Cells after Co-Treatment with Eugenol and Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand
    Hyun Hee Kim et al, 2024, Cancers CrossRef
61. A Customizable Platform to Integrate CAR and Conditional Expression of Immunotherapeutics in T Cells
    Huong T. X. Nguyen et al, 2024, IJMS CrossRef
62. Study of TRAIL and SAHA Co-Treatment on Leukemia K562 Cell Line
    Amirarsalan Alaei et al, 2024, Cell Biochem Biophys CrossRef